Astellas Pharma Inc. (TYO: 4503)
Japan
· Delayed Price · Currency is JPY 1,485.50
-8.50 (-0.57%)
Jan 20, 2025, 3:30 PM JST
Astellas Pharma Revenue
Astellas Pharma had revenue of 462.50B JPY in the quarter ending September 30, 2024, with 17.94% growth. This brings the company's revenue in the last twelve months to 1.77T, up 16.32% year-over-year. In the fiscal year ending March 31, 2024, Astellas Pharma had annual revenue of 1.60T with 5.60% growth.
Revenue (ttm)
1,772.16B
Revenue Growth
+16.32%
P/S Ratio
1.50
Revenue / Employee
120.11M
Employees
14,754
Market Cap
2,663.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 1,603.67B | 85.05B | 5.60% |
| Mar 31, 2023 | 1,518.62B | 222.46B | 17.16% |
| Mar 31, 2022 | 1,296.16B | 46.64B | 3.73% |
| Mar 31, 2021 | 1,249.53B | -51.32B | -3.94% |
| Mar 31, 2020 | 1,300.84B | -5.51B | -0.42% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,142.35B |
| Daiichi Sankyo Company | 1,758.07B |
| HOYA Corporation | 812.74B |
| Takeda Pharmaceutical Company | 4,546.08B |
| Otsuka Holdings | 2,269.56B |
| Terumo | 986.67B |
| Olympus | 973.60B |
| Shionogi & | 418.51B |
Astellas Pharma News
- 25 days ago - Pharma Giant Warns Pills Critical For Organ Transplant Patients' to Survive May Be Completely Empty in Urgent Recall - IBTimes
- 26 days ago - Axcelead DDP Enters into Drug Discovery Service Agreement with Astellas for Targeted Protein Degraders - Business Wire
- 4 weeks ago - Sangamo spikes on Astellas licensing deal for gene therapy tech - Seeking Alpha
- 6 weeks ago - Astellas and Dr. Jen Ashton launch "Cooler Moments" to Spotlight Menopausal Hot Flashes and Empower Women to Advocate for Themselves - PRNewsWire
- 2 months ago - Astellas Announces Desert Oasis Healthcare as First Health System to Implement DIGITIVA™ for Heart Failure Management - PRNewsWire
- 2 months ago - Astellas Pharma Inc. (ALPMF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Astellas: Can The Gastric Cancer Approval Be The Inflection Point? - Seeking Alpha
- 2 months ago - Astellas Pharma reports H1 results - Seeking Alpha